Personal information

Emails & domains

Verified email domains

Other IDs

ResearcherID: A-4799-2015
Scopus Author ID: 7401890001

Countries

United States

Activities

Collapse all

Works (50 of 90)

Items per page:
Page 1 of 2

New Directions in Phosphorus Management in Dialysis

Journal of Renal Nutrition
2023 | Journal article
DOI: 10.1053/j.jrn.2022.04.006
EID:

2-s2.0-85132927994

Part of ISSN: 10512276
Contributors: Dwyer, J.P.; Kelepouris, E.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Impact of Sodium Zirconium Cyclosilicate Plus Renin–Angiotensin–Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study

Advances in Therapy
2023-11 | Journal article
DOI: 10.1007/s12325-023-02631-w
Contributors: Jamie P. Dwyer; Abiy Agiro; Pooja Desai; Yemisi Oluwatosin
Source: check_circle
Crossref

Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study

ClinicoEconomics and Outcomes Research
2023-09 | Journal article
DOI: 10.2147/CEOR.S420217
Contributors: Abiy Agiro; Jamie P Dwyer; Yemisi Oluwatosin; Pooja Desai
Source: check_circle
Crossref

Antihypertensive drug effects on long-term blood pressure: An individual-level data meta-analysis of randomised clinical trials

Heart
2022 | Journal article
DOI: 10.1136/heartjnl-2021-320171
EID:

2-s2.0-85127702845

Part of ISSN: 1468201X 13556037
Contributors: Canoy, D.; Copland, E.; Nazarzadeh, M.; Ramakrishnan, R.; Pinho-Gomes, A.-C.; Salam, A.; Dwyer, J.P.; Farzadfar, F.; Sundström, J.; Woodward, M. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

The Lancet Diabetes and Endocrinology
2022 | Journal article
DOI: 10.1016/S2213-8587(22)00172-3
EID:

2-s2.0-85136245683

Part of ISSN: 22138595 22138587
Contributors: Nazarzadeh, M.; Bidel, Z.; Canoy, D.; Copland, E.; Bennett, D.A.; Dehghan, A.; Davey Smith, G.; Holman, R.R.; Woodward, M.; Gupta, A. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial

Diabetes Care
2022 | Journal article
DOI: 10.2337/dc22-0382
EID:

2-s2.0-85139375303

Part of ISSN: 19355548 01495992
Contributors: Mosenzon, O.; Raz, I.; Wiviott, S.D.; Schechter, M.; Goodrich, E.L.; Yanuv, I.; Rozenberg, A.; Murphy, S.A.; Zelniker, T.A.; Langkilde, A.M. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Diabetic Proteinuria Revisited: Updated Physiologic Perspectives

Cells
2022 | Journal article
DOI: 10.3390/cells11182917
EID:

2-s2.0-85138348655

Part of ISSN: 20734409
Contributors: Heyman, S.N.; Raz, I.; Dwyer, J.P.; Weinberg Sibony, R.; Lewis, J.B.; Abassi, Z.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure

American Journal of Kidney Diseases
2022 | Journal article
DOI: 10.1053/j.ajkd.2021.07.024
EID:

2-s2.0-85121243697

Part of ISSN: 15236838 02726386
Contributors: Kurella Tamura, M.; Gaussoin, S.; Pajewski, N.M.; Zaharchuk, G.; Freedman, B.I.; Rapp, S.R.; Auchus, A.P.; Haley, W.E.; Oparil, S.; Kendrick, J. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Kidney International
2022-01 | Journal article
DOI: 10.1016/j.kint.2021.09.005
Contributors: Hiddo J.L. Heerspink; David Cherney; Douwe Postmus; Bergur V. Stefánsson; Glenn M. Chertow; Jamie P. Dwyer; Tom Greene; Mikhail Kosiborod; Anna Maria Langkilde; John J.V. McMurray et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

The Lancet Oncology
2021 | Journal article
DOI: 10.1016/S1470-2045(21)00033-4
EID:

2-s2.0-85103425918

Part of ISSN: 14745488 14702045
Contributors: Copland, E.; Canoy, D.; Nazarzadeh, M.; Bidel, Z.; Ramakrishnan, R.; Woodward, M.; Chalmers, J.; Teo, K.K.; Pepine, C.J.; Davis, B.R. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Effect of antihypertensive drug treatment on long-term blood pressure reduction: An individual patient-level data meta-analysis of 352,744 Participants from 51 large-scale randomised clinical trials

medRxiv
2021 | Other
DOI: 10.1101/2021.02.19.21252066
EID:

2-s2.0-85103533463
Contributors: Canoy, D.; Copland, E.; Nazarzadeh, M.; Ramakrishnan, R.; Pinho-Gomes, A.-C.; Salam, A.; Dwyer, J.; Farzadfar, F.; Sundström, J.; Woodward, M. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

The Lancet
2021 | Journal article
DOI: 10.1016/S0140-6736(21)00590-0
EID:

2-s2.0-85104906763

Part of ISSN: 1474547X 01406736
Contributors: Adler, A.; Agodoa, L.; Algra, A.; Asselbergs, F.W.; Beckett, N.S.; Berge, E.; Black, H.; Brouwers, F.P.J.; Brown, M.; Bulpitt, C.J. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.

Lancet (London, England)
2021-08 | Journal article
DOI: 10.1016/s0140-6736(21)01921-8
PMID: 34461040
PMC: PMC8473559
Contributors: Blood Pressure Lowering Treatment Trialists' Collaboration
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience.

Journal of cardiac failure
2021-08 | Journal article
DOI: 10.1016/j.cardfail.2021.07.016
PMID: 34403831
Contributors: Cox ZL; Sarrell BA; Cella MK; Tucker B; Arroyo JP; Umanath K; Tidwell W; Guide A; Testani JM; Lewis JB et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.

JAMA cardiology
2021-07 | Journal article
DOI: 10.1001/jamacardio.2021.0660
PMID: 33851953
Contributors: Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.

Diabetes care
2021-07 | Journal article
DOI: 10.2337/dc21-0076
PMID: 34233928
PMC: PMC8385472
Contributors: Mosenzon O; Wiviott SD; Heerspink HJL; Dwyer JP; Cahn A; Goodrich EL; Rozenberg A; Schechter M; Yanuv I; Murphy SA et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial.

JAMA neurology
2021-05 | Journal article
DOI: 10.1001/jamaneurol.2021.0178
PMID: 33683313
PMC: PMC7941253
Contributors: Nasrallah IM; Gaussoin SA; Pomponio R; Dolui S; Erus G; Wright CB; Launer LJ; Detre JA; Wolk DA; Davatzikos C et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central

Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.

The New England journal of medicine
2021-05 | Journal article
DOI: 10.1056/nejmoa1901281
PMID: 34010531
Contributors: SPRINT Research Group; Lewis CE; Fine LJ; Beddhu S; Cheung AK; Cushman WC; Cutler JA; Evans GW; Johnson KC; Kitzman DW et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central

Rationale and protocol of the Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Nephrology Dialysis Transplantation
2020 | Journal article
DOI: 10.1093/ndt/gfz290
EID:

2-s2.0-85079082162

Part of ISSN: 14602385 09310509
Contributors: Heerspink, H.J.L.; Stefansson, B.V.; Chertow, G.M.; Correa-Rotter, R.; Greene, T.; Hou, F.-F.; Lindberg, M.; McMurray, J.; Rossing, P.; Toto, R. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice.

JAMA internal medicine
2020-12 | Journal article
DOI: 10.1001/jamainternmed.2020.5028
PMID: 33044494
PMC: PMC7551238
Contributors: Drawz PE; Agarwal A; Dwyer JP; Horwitz E; Lash J; Lenoir K; McWilliams A; Oparil S; Rahbari-Oskoui F; Rahman M et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

The New England journal of medicine
2020-11 | Journal article
DOI: 10.1056/nejmoa2030186
PMID: 33200891
Contributors: Bhatt DL; Szarek M; Pitt B; Cannon CP; Leiter LA; McGuire DK; Lewis JB; Riddle MC; Inzucchi SE; Kosiborod MN et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2020-10 | Journal article
DOI: 10.1093/ndt/gfaa234
PMID: 32862232
PMC: PMC7538235
Contributors: Wheeler DC; Stefansson BV; Batiushin M; Bilchenko O; Cherney DZI; Chertow GM; Douthat W; Dwyer JP; Escudero E; Pecoits-Filho R et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

COVID-19 and the Inpatient Dialysis Unit: Managing Resources during Contingency Planning Pre-Crisis.

Clinical journal of the American Society of Nephrology : CJASN
2020-04 | Journal article
DOI: 10.2215/cjn.03750320
PMID: 32245780
PMC: PMC7269221
Contributors: Burgner A; Ikizler TA; Dwyer JP
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

The Lancet Diabetes and Endocrinology
2019 | Journal article
DOI: 10.1016/S2213-8587(18)30314-0
EID:

2-s2.0-85060310364

Part of ISSN: 22138595 22138587
Contributors: Heerspink, H.J.L.; Greene, T.; Tighiouart, H.; Gansevoort, R.T.; Coresh, J.; Simon, A.L.; Chan, T.M.; Hou, F.F.; Lewis, J.B.; Locatelli, F. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Journal of the American Society of Nephrology : JASN
2019-07 | Journal article
DOI: 10.1681/asn.2018121261
PMID: 31324734
PMC: PMC6683716
Contributors: Beddhu S; Shen J; Cheung AK; Kimmel PL; Chertow GM; Wei G; Boucher RE; Chonchol M; Arman F; Campbell RC et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.

The lancet. Diabetes & endocrinology
2019-06 | Journal article
DOI: 10.1016/s2213-8587(19)30180-9
PMID: 31196815
Contributors: Mosenzon O; Wiviott SD; Cahn A; Rozenberg A; Yanuv I; Goodrich EL; Murphy SA; Heerspink HJL; Zelniker TA; Dwyer JP et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney international
2019-05 | Journal article
DOI: 10.1016/j.kint.2018.12.025
PMID: 31010478
Contributors: Cheung AK; Chang TI; Cushman WC; Furth SL; Ix JH; Pecoits-Filho R; Perkovic V; Sarnak MJ; Tobe SW; Tomson CRV et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Assessment of Blood Pressure: Techniques and Implications From Clinical Trials.

Advances in chronic kidney disease
2019-03 | Journal article
DOI: 10.1053/j.ackd.2019.02.002
PMID: 31023452
Contributors: Waguespack DR; Dwyer JP
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Once-Daily Plazomicin for Complicated Urinary Tract Infections.

The New England journal of medicine
2019-02 | Journal article
DOI: 10.1056/nejmoa1801467
PMID: 30786187
Contributors: Wagenlehner FME; Cloutier DJ; Komirenko AS; Cebrik DS; Krause KM; Keepers TR; Connolly LE; Miller LG; Friedland I; Dwyer JP et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

The New England journal of medicine
2019-02 | Journal article
DOI: 10.1056/nejmc1807634
PMID: 30786196
Contributors: McKinnell JA; Dwyer JP; Talbot GH; Connolly LE; Friedland I; Smith A; Jubb AM; Serio AW; Krause KM; Daikos GL et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.

Circulation
2019-01 | Journal article
DOI: 10.1161/circulationaha.118.038341
PMID: 30586726
Contributors: Scirica BM; Bohula EA; Dwyer JP; Qamar A; Inzucchi SE; McGuire DK; Keech AC; Smith SR; Murphy SA; Im K et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN Trials

Pharmacotherapy
2018 | Journal article
DOI: 10.1002/phar.2165
EID:

2-s2.0-85052801263

Part of ISSN: 18759114 02770008
Contributors: Nogid, B.; Lacy, M.K.; Jacobs, M.; Bruss, J.; Dwyer, J.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.

Lancet (London, England)
2018-10 | Journal article
DOI: 10.1016/s0140-6736(18)32328-6
PMID: 30293771
Contributors: Bohula EA; Scirica BM; Inzucchi SE; McGuire DK; Keech AC; Smith SR; Kanevsky E; Murphy SA; Leiter LA; Dwyer JP et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants

PLOS ONE
2018-09-26 | Journal article
DOI: 10.1371/journal.pone.0203305
Contributors: Mark A. Supiano; Yan Li; Laura Lovato; Walter T. Ambrosius; Jeffrey Bates; Srinivasan Beddhu; Paul Drawz; Jamie P. Dwyer; Naomi M. Hamburg; Dalane Kitzman et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).

Hypertension (Dallas, Tex. : 1979)
2018-04 | Journal article
DOI: 10.1161/hypertensionaha.117.10646
PMID: 29712745
PMC: PMC5945323
Contributors: Shapiro BP; Ambrosius WT; Blackshear JL; Cushman WC; Whelton PK; Oparil S; Beddhu S; Dwyer JP; Gren LH; Kostis WJ et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney international
2018-04 | Journal article
DOI: 10.1016/j.kint.2018.02.006
PMID: 29656903
PMC: PMC5998808
Contributors: Eckardt KU; Bansal N; Coresh J; Evans M; Grams ME; Herzog CA; James MT; Heerspink HJL; Pollock CA; Stevens PE et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.

Kidney international
2018-03 | Journal article
DOI: 10.1016/j.kint.2017.12.011
PMID: 29526502
Contributors: Toth PP; Dwyer JP; Cannon CP; Colhoun HM; Rader DJ; Upadhyay A; Louie MJ; Koren A; Letierce A; Mandel J et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis

Hemodialysis International
2017 | Journal article
DOI: 10.1111/hdi.12487
EID:

2-s2.0-84994056174

Part of ISSN: 15424758 14927535
Contributors: Jalal, D.; McFadden, M.; Dwyer, J.P.; Umanath, K.; Aguilar, E.; Yagil, Y.; Greco, B.; Sika, M.; Lewis, J.B.; Greene, T. et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).

American journal of kidney diseases : the official journal of the National Kidney Foundation
2017-11 | Journal article
DOI: 10.1053/j.ajkd.2017.08.021
PMID: 29162340
PMC: PMC5828778
Contributors: Rocco MV; Sink KM; Lovato LC; Wolfgram DF; Wiegmann TB; Wall BM; Umanath K; Rahbari-Oskoui F; Porter AC; Pisoni R et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?

Clinical journal of the American Society of Nephrology : CJASN
2017-09 | Journal article
DOI: 10.2215/cjn.09590916
PMID: 28923834
PMC: PMC5628725
Contributors: Weldegiorgis M; de Zeeuw D; Dwyer JP; Mol P; Heerspink HJL
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.

The New England journal of medicine
2017-08 | Journal article
DOI: 10.1056/nejmoa1611179
PMID: 28834483
PMC: PMC5706112
Contributors: Berlowitz DR; Foy CG; Kazis LE; Bolin LP; Conroy MB; Fitzpatrick P; Gure TR; Kimmel PL; Kirchner K; Morisky DE et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central

The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysis
.

Clinical nephrology
2017-03 | Journal article
DOI: 10.5414/cn108924
PMID: 28128726
Contributors: Umanath K; Greco B; Jalal DI; McFadden M; Sika M; Koury MJ; Niecestro R; Hunsicker LG; Greene T; Lewis JB et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes

Diabetes, Obesity and Metabolism
2016 | Journal article
DOI: 10.1111/dom.12583
EID:

2-s2.0-84955189351

Part of ISSN: 14631326 14628902
Contributors: Schievink, B.; Kröpelin, T.; Mulder, S.; Parving, H.-H.; Remuzzi, G.; Dwyer, J.; Vemer, P.; de Zeeuw, D.; Lambers Heerspink, H.J.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.

Hypertension (Dallas, Tex. : 1979)
2016-11 | Journal article
DOI: 10.1161/hypertensionaha.116.08076
PMID: 27849563
PMC: PMC5145774
Contributors: Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.

Diabetes, obesity & metabolism
2016-08 | Journal article
DOI: 10.1111/dom.12708
PMID: 27337598
Contributors: van der Sande NG; Dorresteijn JA; Visseren FL; Dwyer JP; Blankestijn PJ; van der Graaf Y; Heerspink HL
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

We Give Too Much Intravenous Iron.

Seminars in dialysis
2016-05 | Journal article
DOI: 10.1111/sdi.12509
PMID: 27153768
Contributors: Dwyer JP
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.

Neurology
2016-02 | Journal article
DOI: 10.1212/wnl.0000000000002527
PMID: 26920359
PMC: PMC4818564
Contributors: Tamura MK; Pajewski NM; Bryan RN; Weiner DE; Diamond M; Van Buren P; Taylor A; Beddhu S; Rosendorff C; Jahanian H et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central

Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial.

Hypertension (Dallas, Tex. : 1979)
2016-01 | Journal article
DOI: 10.1161/hypertensionaha.115.06851
PMID: 26865200
PMC: PMC4755350
Contributors: Chang TI; Evans G; Cheung AK; Cushman WC; Diamond MJ; Dwyer JP; Huan Y; Kitzman D; Kostis JB; Oparil S et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
grade
Preferred source (of 2)‎

Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data

Drugs in R and D
2015 | Journal article
DOI: 10.1007/s40268-015-0103-y
EID:

2-s2.0-84941188366

Part of ISSN: 11796901 11745886
Contributors: Rodby, R.A.; Umanath, K.; Niecestro, R.; Christopher Bond, T.; Sika, M.; Lewis, J.; Dwyer, J.P.
Source: Self-asserted source
Jamie P Dwyer, MD via Scopus - Elsevier

A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

The New England journal of medicine
2015-11 | Journal article
DOI: 10.1056/nejmoa1511939
PMID: 26551272
PMC: PMC4689591
Contributors: SPRINT Research Group; Wright JT; Williamson JD; Whelton PK; Snyder JK; Sink KM; Rocco MV; Reboussin DM; Rahman M; Oparil S et al.
Source: Self-asserted source
Jamie P Dwyer, MD via Europe PubMed Central
Items per page:
Page 1 of 2
How many people are using ORCID?